In terms of regulation 30 of the SEBI (LODR) Regulations, 2015, Jagsonpal Pharmaceuticals has informed that it enclosed a copy of the Press Release on the Unaudited Financial results of the Company for the quarter ended 30th June, 2021.
The above information is a part of company’s filings submitted to BSE.